Young‐Don Joo

1.9k total citations
59 papers, 1.2k citations indexed

About

Young‐Don Joo is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Young‐Don Joo has authored 59 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 18 papers in Oncology and 11 papers in Immunology. Recurrent topics in Young‐Don Joo's work include Acute Myeloid Leukemia Research (19 papers), Hematopoietic Stem Cell Transplantation (18 papers) and Multiple Myeloma Research and Treatments (9 papers). Young‐Don Joo is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Hematopoietic Stem Cell Transplantation (18 papers) and Multiple Myeloma Research and Treatments (9 papers). Young‐Don Joo collaborates with scholars based in South Korea, United States and Ethiopia. Young‐Don Joo's co-authors include Ki-Ho Han, Song‐I Han, Inhak Choi, Won-Sik Lee, Su‐Kil Seo, Kyoo‐Hyung Lee, Je‐Hwan Lee, Jung‐Hee Lee, Hawk Kim and Dae‐Young Kim and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Analytical Chemistry.

In The Last Decade

Young‐Don Joo

57 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Young‐Don Joo South Korea 19 518 309 299 232 211 59 1.2k
Rajneesh Nath United States 18 273 0.5× 426 1.4× 99 0.3× 162 0.7× 305 1.4× 58 1.0k
Swati Naik United States 16 172 0.3× 561 1.8× 125 0.4× 272 1.2× 238 1.1× 90 1.0k
Cristina Gutiérrez United States 11 153 0.3× 1.6k 5.1× 479 1.6× 449 1.9× 387 1.8× 35 1.9k
Wenhao Zhang China 16 139 0.3× 391 1.3× 54 0.2× 298 1.3× 288 1.4× 88 898
Walentyna Balwierz Poland 15 168 0.3× 196 0.6× 81 0.3× 70 0.3× 280 1.3× 123 1.1k
Weiyan Zheng China 14 351 0.7× 199 0.6× 32 0.1× 167 0.7× 240 1.1× 71 800
Yoko Miura Germany 22 189 0.4× 93 0.3× 131 0.4× 253 1.1× 443 2.1× 91 1.3k
Joseph E. Gootenberg United States 18 204 0.4× 408 1.3× 76 0.3× 251 1.1× 233 1.1× 25 1.4k
Patrick M. Reagan United States 19 50 0.1× 949 3.1× 144 0.5× 366 1.6× 258 1.2× 83 1.3k
Giulia Barbiera Italy 4 93 0.2× 842 2.7× 294 1.0× 322 1.4× 250 1.2× 6 1.1k

Countries citing papers authored by Young‐Don Joo

Since Specialization
Citations

This map shows the geographic impact of Young‐Don Joo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young‐Don Joo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young‐Don Joo more than expected).

Fields of papers citing papers by Young‐Don Joo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Young‐Don Joo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young‐Don Joo. The network helps show where Young‐Don Joo may publish in the future.

Co-authorship network of co-authors of Young‐Don Joo

This figure shows the co-authorship network connecting the top 25 collaborators of Young‐Don Joo. A scholar is included among the top collaborators of Young‐Don Joo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Young‐Don Joo. Young‐Don Joo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Kyoo‐Hyung, Je‐Hwan Lee, Jung‐Hee Lee, et al.. (2017). Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission. Biology of Blood and Marrow Transplantation. 23(9). 1555–1566. 18 indexed citations
2.
Lee, Je‐Hwan, Yunsuk Choi, Dae‐Young Kim, et al.. (2014). Clinical outcome after failure of hypomethylating therapy for myelodysplastic syndrome. European Journal Of Haematology. 94(6). 546–553. 10 indexed citations
4.
Lee, Je‐Hwan, Yunsuk Choi, Sung-Doo Kim, et al.. (2013). Comparison of 7-day azacitidine and 5-day decitabine for treating myelodysplastic syndrome. Annals of Hematology. 92(7). 889–897. 20 indexed citations
5.
Lee, Je‐Hwan, Young‐Don Joo, Hawk Kim, et al.. (2012). Randomized Trial of Myeloablative Conditioning Regimens: Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine. Journal of Clinical Oncology. 31(6). 701–709. 77 indexed citations
7.
Lee, Won-Sik, Young‐Don Joo, Sunmi ‍Lee, et al.. (2012). G-CSF-induced myeloid cells stimulated by TLR2 enhance engraftment after allogeneic hematopoietic stem cell transplantation. Immunology Letters. 143(2). 177–183. 1 indexed citations
8.
Joo, Young‐Don, Won-Sik Lee, Hye Ran Kim, et al.. (2012). G-CSF-treated donor CD4+ T cells attenuate acute GVHD through a reduction in Th17 cell differentiation. Cytokine. 60(1). 277–283. 8 indexed citations
9.
Han, Song‐I, Sang‐Min Lee, Young‐Don Joo, & Ki-Ho Han. (2011). Lateral dielectrophoretic microseparators to measure the size distribution of blood cells. Lab on a Chip. 11(22). 3864–3864. 30 indexed citations
10.
Lee, Kyoo‐Hyung, Seong‐Jun Choi, Je‐Hwan Lee, et al.. (2011). Clinical effect of reduced‐intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated‐donors. American Journal of Hematology. 86(5). 399–405. 9 indexed citations
12.
Lee, Je‐Hwan, Kyoo‐Hyung Lee, Jung‐Hee Lee, et al.. (2010). Decreased incidence of febrile episodes with antibiotic prophylaxis in the treatment of decitabine for myelodysplastic syndrome. Leukemia Research. 35(4). 499–503. 25 indexed citations
13.
Lee, Ji Hyun, Kyung A Kwon, Suee Lee, et al.. (2010). Incidence and clinical characteristics of clonal cytogenetic abnormalities of acquired aplastic anemia in adults. The Korean Journal of Hematology. 45(4). 242–242. 2 indexed citations
15.
Chung, Joo Seop, et al.. (2009). Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia?. European Journal Of Haematology. 83(1). 72–78. 10 indexed citations
16.
Kim, Seok Jin, Kihyun Kım, Byung‐Soo Kim, et al.. (2008). Bortezomib and the Increased Incidence of Herpes Zoster in Patients with Multiple Myeloma. Clinical Lymphoma & Myeloma. 8(4). 237–240. 48 indexed citations
17.
Kim, Seok Jin, Hyo Jin Lee, Hawk Kim, et al.. (2007). Varicella Zoster Virus Reactivation with the Use of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients.. Blood. 110(11). 4843–4843.
18.
Kim, Dong-Soo, Doo‐Il Kim, Jae-Ik Lee, et al.. (2006). A case of familial primary pulmonary hypertension. The Korean Journal of Internal Medicine. 70(3). 312–317.
19.
Kim, Jong Gwang, Sang Kyun Sohn, Yee Soo Chae, et al.. (2005). CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas. Cancer Chemotherapy and Pharmacology. 58(1). 35–39. 45 indexed citations
20.
Lee, Je‐Hwan, Young‐Don Joo, Daesong Yim, et al.. (2004). Molecular cloning and characterization of canine ICOS. Genomics. 84(4). 730–736. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026